Kyverna Therapeutics, Inc.
KYTXBiotechnology
$5.85−0.68%As of Oct 29vs prior close
- Market cap
- $361.8M
- P/E (TTM)
- –
- From 52W high
- −48.00%
- EPS (LTM)
- -$2.93
- Dividend yield
- 0.00%
Nomior Score
29
Fragile PremiumBottom 14% of the scored universe
Growth—
Quality38
Value32
Momentum42
Resilience31
Connections
Who owns it
2funds